SCHEMBL25377894

SCHEMBL25377894

COC(=O)Cc1ccc(Br)cc1F.COC(=O)Cc1ccc(C2=CCN(C(=O)OC(C)(C)C)CC2)cc1F

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 1/20 0.50
▸ NAMPT P43490 1/20 0.47
▸ PDK4 Q16654 1/20 0.43
▸ GRM1 Q13255 8/20 0.43
▸ GRM5 P41594 7/20 0.43
▸ USP30 Q70CQ3 1/20 0.41
▸ CDK7 P50613 1/20 0.41
▸ CDK13 Q14004 1/20 0.41
▸ CDK12 Q9NYV4 1/20 0.41
▸ WNT3A P56704 1/20 0.41
▸ SOS1 Q07889 1/20 0.40
▸ LIPC P11150 1/20 0.40
▸ LIPG Q9Y5X9 1/20 0.40
▸ BRD4 O60885 1/20 0.39
▸ CDK9 P50750 2/20 0.39
▸ CCNT1 O60563 1/20 0.39
▸ PRMT5 O14744 1/20 0.39
▸ WDR77 Q9BQA1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30582088 1.00 TLR7 (0.50) TLR7NAMPTPDK4GRM1GRM5
SCHEMBL24319593 0.85 TLR7 (0.52) TLR7NAMPTPDK4GRM1GRM5
SCHEMBL578028 0.81 NAMPT (0.60) NAMPTPDK4GRM1GRM5CDK7
SCHEMBL29707399 0.81 TLR7 (0.53) TLR7NAMPTPDK4GRM1GRM5
SCHEMBL30722230 0.81 NAMPT (0.53) TLR7NAMPTPDK4GRM1GRM5
SCHEMBL1198658 0.81 NAMPT (0.53) TLR7NAMPTPDK4GRM1GRM5
SCHEMBL25378040 0.80 PDK4 (0.48) NAMPTPDK4GRM1GRM5CDK7
SCHEMBL30582019 0.80 PDK4 (0.48) NAMPTPDK4GRM1GRM5CDK7
SCHEMBL14990423 0.80 NAMPT (0.57) NAMPTPDK4GRM1GRM5CDK7
SCHEMBL31174297 0.79 NAMPT (0.56) TLR7NAMPTPDK4GRM1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023161317-A1 5-[7-(3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBONYL)-1,2,3,4 TETRAHYDROISOQUINOLIN-6-Y L]-1H-PYRROLE-3-CARBOXAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS LES LABORATOIRES SERVIER (FR) 2023-08-31 — — WO disclosed
Send feedback